Effectiveness of cord blood transplantation for the treatment of refractory angioimmunoblastic T-cell lymphoma: a series of three cases

Bone Marrow Transplant. 2019 Oct;54(10):1710-1712. doi: 10.1038/s41409-019-0494-4. Epub 2019 Feb 26.

Authors

Yasuhiro Kazuma¹, Yayoi Shimazu^{1

2}, Masakatsu Hishizawa³, Momoko Nishikori¹, Toshiyuki Kitano^{1

4}, Tadakazu Kondo¹, Kouhei Yamashita¹, Akifumi Takaori-Kondo¹

Affiliations

¹ Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
² Department of Hematology, Japanese Red Cross Wakayama Medical Center, Wakayama, Japan.
³ Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan. hishiza@kuhp.kyoto-u.ac.jp.
⁴ Department of Hematology, Medical Research Institute Kitano Hospital, Osaka, Japan.

PMID: 30809041
DOI: 10.1038/s41409-019-0494-4

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Cord Blood Stem Cell Transplantation / methods*
Humans
Immunoblastic Lymphadenopathy / mortality
Immunoblastic Lymphadenopathy / therapy*
Male
Middle Aged
Survival Analysis